<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[The Pulse by Wharton Digital Health - Medium]]></title>
        <description><![CDATA[Capturing the pulse of healthcare innovation spanning leaders across the healthcare ecosystem - Medium]]></description>
        <link>https://medium.com/wharton-pulse-podcast?source=rss----f7926dfebeed---4</link>
        <image>
            <url>https://cdn-images-1.medium.com/proxy/1*TGH72Nnw24QL3iV9IOm4VA.png</url>
            <title>The Pulse by Wharton Digital Health - Medium</title>
            <link>https://medium.com/wharton-pulse-podcast?source=rss----f7926dfebeed---4</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Wed, 18 Nov 2026 03:44:42 GMT</lastBuildDate>
        <atom:link href="https://medium.com/feed/wharton-pulse-podcast" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Dr. Arpan Parikh, Kin Health, on Building the Patient-Side AI Scribe That Healthcare Has Been...]]></title>
            <link>https://medium.com/wharton-pulse-podcast/dr-arpan-parikh-kin-health-on-building-the-patient-side-ai-scribe-that-healthcare-has-been-3f142b8eb03e?source=rss----f7926dfebeed---4</link>
            <guid isPermaLink="false">https://medium.com/p/3f142b8eb03e</guid>
            <category><![CDATA[consumer-health]]></category>
            <category><![CDATA[scribe]]></category>
            <category><![CDATA[digital-health]]></category>
            <dc:creator><![CDATA[Chase Riley]]></dc:creator>
            <pubDate>Wed, 04 Nov 2026 14:01:04 GMT</pubDate>
            <atom:updated>2026-11-04T14:01:03.642Z</atom:updated>
            <content:encoded><![CDATA[<h3><strong>Dr. Arpan Parikh, Kin Health, on Building the Patient-Side AI Scribe That Healthcare Has Been Missing</strong></h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/800/1*s5uySiGcHc3fYxPR9RCCSw.png" /><figcaption>Arpan Parikh, MD, Co-founder &amp; CEO of Kin Health</figcaption></figure><p>In this episode of <em>The Pulse</em>, I sat down with <a href="https://www.linkedin.com/in/arpanparikhmd/"><strong>Dr. Arpan Parikh</strong></a>, co-founder and CEO of<a href="https://www.meetkin.com/?utm_source=search&amp;utm_medium=google_ads&amp;utm_campaign=gads_search_brand_us_launch_v1&amp;utm_term=brand_exact_core&amp;utm_content=826170786153&amp;campaign_id=23841411828&amp;ad_set_id=194276722537&amp;ad_id=826170786153&amp;keyword=kin%20health&amp;matchtype=e&amp;device=c&amp;gad_source=1&amp;gad_campaignid=23841411828&amp;gbraid=0AAAABDZy1m_xPIQLrm00qEGC5pWAr2Dfx&amp;gclid=CjwKCAiAhqHXBhAXEiwATbksU67Q1awONGlJIZIyqtS2Y8UzRCy6ZGQDnNHWpcP1CXUmwE7UKT_RERoCUNcQAvD_BwE"> <strong>Kin Health</strong></a>, a mobile app that records doctor visits and turns them into plain-language summaries with clear next steps. Arpan has a unique connection to the show: he sat in this very chair as an MBA student in Wharton’s Healthcare Management program and served as a co-host of The Pulse. Since then, he’s built his career at the intersection of psychiatry and healthcare operations, holding leadership roles including Chief Medical Officer of SOL Mental Health and National Director of Behavioral Health at CareMore. Arpan co-founded Kin with his brother Amit Parikh and CTO Kyle Alwyn, and the company launched this past May with a $9 million seed round led by Maveron.</p><p>In our conversation, Arpan and I explored:</p><ul><li>His path from clinical psychiatry to healthcare operations and entrepreneurship</li><li>How three co-founders, including his brother, came together through the Wharton network</li><li>Why Kin is free for patients and what that means for the business model</li><li>How Kin’s tech stack stays model-agnostic and what the company’s internal AI infrastructure looks like</li><li>Why provider-side scribes don’t solve the patient-side problem</li><li>What Kin’s distribution through physician practices and health plans means for its competitive moat</li></ul><h3>From Psychiatry to the Business of Healthcare</h3><p>Arpan’s father was a psychiatrist, but he kept an open mind through medical school. However, a third-year rotation at Twin Valley, a forensic psychiatric unit in Columbus, Ohio, solidified his interest in the specialty. Psychiatry gave him 60 to 90 minutes to sit with a patient and listen.</p><p><em>“What other specialty does a doctor get to spend an hour and a half with a patient? What an incredible job.”</em></p><p>The patients were among the most marginalized in healthcare, and the specialty itself was the most stigmatized in medicine, which gave the work a sense of purpose beyond the clinic.</p><p>After training in adult psychiatry and addiction medicine in New York City, Arpan landed a role at Mount Sinai that was 80% clinical and 20% operational, and it was the operational side that exposed how little medical school actually teaches about the healthcare system.</p><p>When his fiancée (now wife) began applying to business school, Arpan tagged along on campus visits, noticed programs with healthcare concentrations, applied, and landed himself at Wharton’s Healthcare Management program.</p><h3>How the Founding Team Came Together</h3><p>The idea for Kin came to Arpan in mid-August 2025, and one of the first people he called was his brother Amit, a fellow double board-certified psychiatrist and digital health executive. The two had talked about building something together for years, but the timing had never aligned until then.</p><p>Neither Arpan nor Amit is a software engineer, so the technical co-founder search was critical. A former Wharton MBA student connected Arpan to Trevor Bezdek, co-founder and former co-CEO of GoodRx, who had been exploring something similar. Trevor and his GoodRx co-founder Doug Hirsch came on as partners and connected the Parikh brothers to Kyle Alwyn, an engineer and healthcare company builder whose prior telemedicine company GoodRx had acquired.</p><h3>What Kin Is and Why It Has to Be Free</h3><p>Kin is a patient and caregiver copilot for healthcare, and today its core function is an ambient notetaker for doctor visits, what Arpan describes as “Granola for patients.” A user records their appointment and within two minutes receives a fifth-grade reading level summary, a checklist of next steps, and the ability to share everything with a spouse, adult child, or caregiver in real time.</p><p>The problem is well documented: the average American doesn’t fully understand most of what their doctor tells them, and forgets 50 to 80 percent of what they do understand by the time they reach the parking lot.</p><p><em>“How can we be surprised that we don’t have great health outcomes in this country? I don’t think we have a clinical problem. I actually think we have the best clinical care on the planet. But where things fall apart is when the patient leaves the exam room, and that’s where all the work happens.”</em></p><p>Kin is completely free for patients, and the founding team’s conviction is that the people who need it most, like a senior on a fixed income managing multiple chronic conditions, can’t afford $5 a month for an app. The company does not sell or train models on user data.</p><h3>The Business Model: Orchestration, Not Subscription</h3><p>Arpan draws a parallel between Kin and GoodRx. As Kin stitches together conversational data across visits, it learns in real time what a user needs next, whether that’s a cardiologist referral, physical therapy appointment, or prescription discount. That creates an orchestration layer where Kin can connect users to fulfillment partners at the moment of need.</p><p>The company is taking a “crawl-walk-run” approach: surfacing relevant partners in Q4 2026, more active orchestration in Q1 2027, and seamless background booking by mid-2027, always with user permission.</p><p><em>“Imagine you walk out of a doctor’s office, the doctor told you to do five things, and now you have an app on your phone that’s already gone and gotten you those five things before you reach your car. That’s an incredible experience as a patient in America.”</em></p><p>Kin is also in conversations with health plans across commercial, Medicare Advantage, and Medicaid. The value proposition is that a tool that reduces post-visit information loss can drive 1–2.5% in total cost of care savings, which is significant margin uplift.</p><h3>Why Provider-Side Scribes Don’t Solve the Patient Problem</h3><p>The clinical AI scribe market (Abridge, Ambience, Microsoft, Epic) has attracted significant investment. But Arpan sees a clear line between those products and what Kin is building, and frames the moat in three ways.</p><p>First, building a delightful consumer product is a fundamentally different motion than building enterprise B2B SaaS. The largest EHR’s patient-facing product has a negative net promoter score. Kin has built something simple enough that older adults who have never used ChatGPT use it multiple times a week.</p><p>Second, he emphasizes trust. Kin was built by two practicing, double board-certified physicians for patients. In a category where consumers have no awareness of the existing players or a net-negative perception, physician founders carry real weight.</p><p>Third, the company is being thoughtful about distribution. Kin’s B2B2C channel, where practices and health plans recommend the app at the point of care, is hard to replicate. No physician in America is telling a patient to ask ChatGPT before their next visit, but hundreds of practices are already handing out Kin materials in their waiting rooms.</p><p><em>“Our moats aren’t impenetrable. But being the first mover and defining the category is going to make it hard for others to catch up.”</em></p><h3>Go-to-Market and Who Kin Actually Serves</h3><p>Kin’s power users aren’t coastal tech workers but Americans aged 50 and older in rural America, many of whom use the app multiple times a week.</p><p>The company is now scaling a B2B2C distribution motion mirroring GoodRx: physician practices, ACOs, and risk-bearing groups recommend Kin to patients at the point of care, with collateral in waiting rooms and tear sheets handed out at the front desk.</p><p>Unlike consumer health companies that position themselves as alternatives to the traditional system, Kin is designed to reinforce it. Most Americans, when seriously ill, use the traditional healthcare system, and Kin’s role is to make that experience less confusing and more actionable.</p><p><em>“We don’t want to or need to deliver care because</em> <em>we don’t want to or need to disintermediate the healthcare system. What we want to do is turbocharge the doctor in the academic medical center or in the rural primary care office.”</em></p><h3>Arpan’s Advice for MBA Students and Early-Stage Operators</h3><p>Arpan left two pieces of advice for students considering startups or early-stage healthcare companies.</p><p>First, invest in relationships on campus. The Wharton network has been more valuable to his career than anything else, and the Kin origin story is a testatment to that.</p><p>Second, get “AI-pilled.” Arpan sees a real divide in the talent pool between people who are actively using AI tools and people who are not, and says hands-on experience is one of the first things he screens for when hiring at Kin.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=3f142b8eb03e" width="1" height="1" alt=""><hr><p><a href="https://medium.com/wharton-pulse-podcast/dr-arpan-parikh-kin-health-on-building-the-patient-side-ai-scribe-that-healthcare-has-been-3f142b8eb03e">Dr. Arpan Parikh, Kin Health, on Building the Patient-Side AI Scribe That Healthcare Has Been...</a> was originally published in <a href="https://medium.com/wharton-pulse-podcast">The Pulse by Wharton Digital Health</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Aidan Dewar, Nourish, on Using AI to Build a Better Healthcare System]]></title>
            <link>https://medium.com/wharton-pulse-podcast/aidan-dewar-nourish-on-using-ai-to-build-a-better-healthcare-system-366f63cefa11?source=rss----f7926dfebeed---4</link>
            <guid isPermaLink="false">https://medium.com/p/366f63cefa11</guid>
            <category><![CDATA[entrepreneurship]]></category>
            <category><![CDATA[digital-health]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[ai]]></category>
            <dc:creator><![CDATA[Aneri Patel]]></dc:creator>
            <pubDate>Thu, 21 May 2026 10:31:00 GMT</pubDate>
            <atom:updated>2026-05-21T19:50:47.754Z</atom:updated>
            <content:encoded><![CDATA[<p><em>🎧 Subscribe to The Pulse by Wharton Digital Health on </em><a href="https://podcasts.apple.com/us/podcast/the-pulse-by-wharton-digital-health/id1442422790"><em>Apple</em></a> and <a href="https://open.spotify.com/show/6c3GYfXasBWEDrMMJJ1NmA"><em>Spotify</em></a><em> for more conversations with the leaders reshaping health tech.</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/800/1*yYq1sEDzvmfqknyguJRk9w.jpeg" /></figure><p>In this episode, I had the pleasure of sitting down with Aidan Dewar, Co-Founder and CEO of <a href="http://nourish.com/thepulse">Nourish</a> — a company on a mission to make healthy living more accessible by pairing patients with registered dietitians, technology, and medication to sustain real behavior change.</p><p>Nourish has built the largest network of registered dietitians in the United States and layered virtual physician care, lab testing, and medication management (including GLP-1s) into a single, insurance-covered platform.</p><p>In just over four years, the company has gone from a simple virtual dietitian booking platform to a full-stack virtual clinic, tripling revenue year over year and recently closing a $100 million Series C.</p><p>In our conversation, Aidan and I explored:</p><ul><li>Why cardiometabolic dysfunction is the most upstream problem in healthcare</li><li>How Nourish built the largest dietitian network in the country</li><li>The role of personalization and AI in making behavior change stick</li><li>How GLP-1s fit (and don’t fit) into a responsible care model</li><li>What it took to raise a $100M Series C in a selective funding environment</li></ul><h3><strong>From Personal Struggles to a Company Mission</strong></h3><p>Nourish grew out of lived experience. Aidan had suffered from chronic migraines for years and resolved them by working with a registered dietitian. His co-founder Sam had a GI condition that nutrition counseling helped manage. Aidan’s mother was diagnosed with Type 2 diabetes and found meaningful improvement through dietary support.</p><blockquote>“We had these really great experiences with registered dietitians and understood this world of lifestyle change as an intervention to deliver clinical outcomes.”</blockquote><p>Paired with a top-down view of the data — trillions of dollars in healthcare spend, hundreds of millions of people struggling with chronic conditions, millions of preventable deaths — the founders became convinced that cardiometabolic dysfunction was the most upstream problem they could tackle.</p><p>The timing felt right for three reasons: the telehealth explosion during COVID had made virtual care not only acceptable but, Aidan argues, actively better for behavior change; AI was opening up new possibilities for 24/7 patient support; and a new generation of medications like GLP-1s was entering the toolkit.</p><h3><strong>Building the Largest Dietitian Network in the Country</strong></h3><p>One of Nourish’s most distinctive assets is its network — 10,000+ registered dietitians, all W-2 employees practicing on the platform. Getting there required understanding why great dietitians might want to join in the first place.</p><p>Before Nourish, delivering high-quality outpatient nutrition care meant going it alone: contracting with insurance companies, handling credentialing and billing, managing customer support, running a back office. Nourish stripped all of that away.</p><blockquote>“On Nourish, you can just focus on delivering really great care — and have access to the largest dietitian community in the US, receive clinical support and technology, and make a really great living, with a flexible schedule and the kind of work that’s motivating and rewarding.”</blockquote><p>Because Nourish employs its providers directly and communicates with them constantly through shared Slack channels, the team gets real-time feedback on pain points, which also proved invaluable for building AI tools that dietitians actually want to use.</p><h3><strong>AI as a Behavior Change Engine</strong></h3><p>When Aidan talks about AI at Nourish, he makes a distinction worth paying attention to: there’s a difference between automating administrative work and accelerating patient-facing care.</p><p>Nourish started with the former. They built a custom EMR in-house with an embedded AI scribe that handles session notes, patient messaging, clinical research prep, and progress summaries. The result: providers spend over 90% less time on administrative tasks outside of sessions.</p><p>The next phase was more ambitious. Nourish used data from millions of appointments to build an AI copilot that actively helps dietitians deliver better care: surfacing the right questions, modeling what drives outcomes, and flagging early signs of disengagement.</p><blockquote>“We’re training a model on millions of appointments and understanding what drives the best clinical outcomes, how you build trust, how you change people’s behavior, and providing that as a built-in assistant to the care delivery workflow.”</blockquote><p>Nourish’s AI health assistant handles everything from meal planning and goal tracking to care coordination — ordering labs, scheduling appointments, answering questions between sessions. The goal is to make behavior change a 24/7 possibility, not something that only happens in a 30-minute window every few weeks.</p><p>A key reason this is possible: Nourish owns its entire tech stack. Rather than building on top of a legacy EMR, Nourish’s co-founder and CTO Stephanie Liu made the early call to build everything in-house.</p><blockquote>“We would just naturally be constrained if we weren’t able to own this in-house. The thing we most want to avoid is making decisions that are actively worse for patients and providers because of a third-party reliance on a software tool.”</blockquote><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*jOqO5EcC3wj7kqsXrcuEeA.png" /></figure><h3><strong>GLP-1s: A Tool, Not a Standalone Solution</strong></h3><p>No conversation about metabolic health in 2026 is complete without GLP-1s, and Nourish has a clear philosophy here. For the first four years of the company, Nourish didn’t prescribe or manage medications at all. Their focus was nutrition counseling and behavior change. But as GLP-1 adoption exploded, health plan partners started asking the company to take on a bigger role: could Nourish be the responsible prescriber and take that on as part of their activities?</p><p>Nourish doesn’t compound medications, doesn’t upcharge, and doesn’t monetize the prescription. If they can’t get the medication covered by insurance, they pass it along at cost from the manufacturers.</p><blockquote>“By combining medication, nutrition counseling, and behavior support, we’ve built a very specific care model where dietitians support patients before they’re ever on a medication, while they’re on it, and most importantly, after.”</blockquote><p>The data backs up the concern: medication alone doesn’t drive durable outcomes. Without lifestyle support, adherence is low, weight regain is common, and health plans see negative ROI. Nourish is betting that the care model is the real moat.</p><h3><strong>Nourish Labs: Making Progress Visible</strong></h3><p>One of the company’s most recent launches is Nourish Labs, which gives patients access to free cardiometabolic biomarker testing directly integrated into their care plan.</p><p>The problem it solves is simple: if you’re working hard to change your metabolic health, how do you know it’s working? External lab services existed, but they were expensive and disconnected from care delivery. On top of that, patients often had no idea how to act on their results.</p><p>With Nourish Labs, dietitians can order labs seamlessly through the platform. Patients coordinate testing within the app and use the AI health agent to schedule, interpret, and track results. Those results then feed directly into treatment plans.</p><blockquote>“When you have this sort of data, it’s more motivating for patients, it helps providers understand what great care looks like, and it gives our health plan partners the data points to show the results we’re delivering.”</blockquote><p>Over 100,000 patients have completed labs within just a few months of launch. Aidan sees this as one of the highest-leverage places to continue investing as part of the Series C raise: more panel types, more integration into the care model, more feedback loops between data and outcomes.</p><h3><strong>Raising a $100M Series C in a Selective Market</strong></h3><p>Digital health fundraising has gotten harder. Investors are more selective and valuations have compressed. Nourish closed a $100M Series C anyway, and did so from a position of strength, not necessity.</p><blockquote>“We were profitable last year. So we were lucky we didn’t have an active need to raise. The interest was more inbound.”</blockquote><p>When asked what investors were looking for that made them confident in the investment, Aidan called out a few things:</p><ul><li>Consistent, accelerating growth. Nourish has tripled revenue year-over-year, with growth actually accelerating at scale.</li><li>A clear win for every stakeholder. Patients get better outcomes. Providers get a great place to practice. Health plans save thousands of dollars per patient per year. Health systems get a referral partner that fills a genuine gap in their care continuum.</li><li>A business model with aligned incentives. Its revenue comes from delivering good care at scale — which means the incentives point in the same direction as the mission.</li></ul><p>The capital will go toward four priorities: growing the clinical network, deepening AI investments, expanding health plan and health system partnerships, and building out the dietitian-led metabolic clinic offering to serve more patients.</p><h3><strong>Advice for Aspiring Founders in Digital Health</strong></h3><p>Aidan closed our conversation with two pieces of advice for students and early-stage founders thinking about building in healthcare:</p><p><strong>1. Go after the biggest problems, not the smallest niches.</strong></p><blockquote>“The instinct is often to try to find niches that no one has touched — parts that feel easier and less daunting. But that instinct is usually wrong. If you’re solving a smaller problem, you’re creating less value, and it’ll be counterintuitively harder.”</blockquote><p>The best people want to work on the most important problems. If your mission doesn’t inspire that, recruiting becomes a self-defeating cycle.</p><p><strong>2. Cultivate agency.</strong></p><p>A lot of what makes healthcare hard is that the status quo has calcified over decades. Regulations, incumbent systems, entrenched workflows. It can feel like the walls are everywhere. Aidan’s advice is to treat those walls as problems to be solved, not facts to be accepted.</p><blockquote>“If it doesn’t violate a law of physics, it can be solved. The most important problems are the ones where it’s easy to accept the status quo as the only way things can be. That’s exactly where the most value is waiting to be created.”</blockquote><h3><strong>Closing Thoughts</strong></h3><p>What struck me most about this conversation was how consistently Aidan returns to a single idea: the best businesses are the ones where doing right by the patient and building a durable company are the same thing, not a trade-off.</p><p>Nourish isn’t charging patients for labs. It isn’t monetizing GLP-1 prescriptions. It isn’t cutting corners on dietitian quality to hit a unit economics target. And yet it’s profitable, growing, and attracting serious investor interest. The bet is that if you build a great consumer experience and earn genuine trust — from patients, providers, plans, and systems — the business follows.</p><p>I think a lot of businesses, in healthcare and beyond, have a lot to learn from Nourish’s dual mandate on scale and outcomes. It’s easy to optimize for one at the expense of the other: grow fast and let quality slip, or obsess over clinical perfection at the cost of reach. Nourish’s framework is that these two things are actually a reinforcing flywheel. Better outcomes build trust with health plans, employers, and health systems, which expands coverage, which drives more patients to the platform, which generates more data, which improves AI models, which drives better outcomes. The companies that figure out how to compound both are the ones that end up mattering.</p><p>This post is based on a conversation recorded for The Pulse by Wharton Digital Health. Listen to the full episode <em>on </em><a href="https://podcasts.apple.com/us/podcast/the-pulse-by-wharton-digital-health/id1442422790"><em>Apple</em></a> and <a href="https://open.spotify.com/show/6c3GYfXasBWEDrMMJJ1NmA"><em>Spotify</em></a><em>.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=366f63cefa11" width="1" height="1" alt=""><hr><p><a href="https://medium.com/wharton-pulse-podcast/aidan-dewar-nourish-on-using-ai-to-build-a-better-healthcare-system-366f63cefa11">Aidan Dewar, Nourish, on Using AI to Build a Better Healthcare System</a> was originally published in <a href="https://medium.com/wharton-pulse-podcast">The Pulse by Wharton Digital Health</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Ellen Rudolph, WellTheory, on rebuilding autoimmune care]]></title>
            <link>https://medium.com/wharton-pulse-podcast/ellen-rudolph-welltheory-on-rebuilding-autoimmune-care-70411ea31c6a?source=rss----f7926dfebeed---4</link>
            <guid isPermaLink="false">https://medium.com/p/70411ea31c6a</guid>
            <category><![CDATA[digital-health]]></category>
            <category><![CDATA[healthcare-technology]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[womens-health]]></category>
            <category><![CDATA[chronic-illness]]></category>
            <dc:creator><![CDATA[Trisha Thacker]]></dc:creator>
            <pubDate>Tue, 19 May 2026 18:27:40 GMT</pubDate>
            <atom:updated>2026-05-19T18:27:42.104Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Jd1BeJVVvwN5KhD-JCQ3tA.jpeg" /><figcaption>Ellen Rudolph, Co-founder and CEO of WellTheory</figcaption></figure><p>In this episode, I had the pleasure of sitting down with <a href="https://www.linkedin.com/in/ellenrudolph/"><strong>Ellen Rudolph</strong></a>, co-founder and CEO of <a href="https://www.welltheory.com/">WellTheory</a>, a virtual care platform rethinking how we diagnose and manage autoimmune disease. WellTheory has raised over $26M in funding from <a href="https://www.generalcatalyst.com/">General Catalyst</a>, which included participation from <a href="https://www.7wireventures.com/">7wire Ventures</a>, <a href="https://www.ingeborginvestments.com/">Ingeborg Investments</a>, <a href="https://www.accel.com/">Accel</a>, <a href="https://www.boxgroup.com/">Box Group</a>, <a href="https://leaps.bayer.com/">Leaps by Bayer </a>and others. Built from her own experience navigating a fragmented and often dismissive healthcare system, WellTheory is grounded in a simple but powerful belief: autoimmune care requires treating root causes, not just symptoms. With over 50 million Americans living with autoimmune conditions, 80% of whom are women, Ellen is building for one of the largest and most overlooked patient populations in healthcare today.</p><p>Before founding WellTheory, Ellen studied product design at Stanford, where she fell in love with the process of identifying a problem, forming a hypothesis, testing it in the real world, and iterating. That engineering instinct, combined with a deeply personal health journey, became the blueprint for WellTheory.</p><p>In our conversation, Ellen and I explored:</p><ul><li>Her personal health journey and the founding of WellTheory</li><li>How WellTheory is redesigning autoimmune care around root causes, not symptoms</li><li>The transition from direct-to-consumer to enterprise</li><li>Autoimmune disease as a women’s health crisis</li><li>Advice for founders and aspiring entrepreneurs</li></ul><p><strong>From patient to founder: building what the healthcare system failed to provide</strong></p><p>Ellen’s path to founding WellTheory began with a deeply personal experience. In her mid-20s, living in New York and climbing the corporate tech ladder, she found herself bedridden: cycling through ER visits and specialist appointments, experiencing everything from fatigue and brain fog to scary neurological symptoms, and being told repeatedly that her labs looked normal or that she was “too young to be sick.” After years of searching, she finally received an autoimmune diagnosis. What followed wasn’t relief — it was frustration.</p><blockquote>“I was essentially handed a prescription band-aid for my symptoms and told to come back once things got worse.”</blockquote><p>Ellen dove into research, discovered the profound impact of dietary and lifestyle interventions, and made it her mission to ensure others didn’t have to navigate that same journey alone. Her co-founders, Claire and Wallace, had their own lives shaped by autoimmune disease, and together, they built WellTheory on a conviction she articulated simply:</p><blockquote>“We founded WellTheory on the really simple premise that this patient population deserves better answers, support, and ultimately better outcomes.”</blockquote><p><strong>Redesigning the fragmented state of autoimmune care</strong></p><p>With over 100 different autoimmune diseases, from lupus to rheumatoid arthritis to psoriasis, patients are typically routed to different specialists depending on where symptoms show up. The result is fragmented care that rarely addresses underlying drivers. WellTheory flips that model. Instead of treating symptoms in isolation, the platform focuses on root causes: stress, nutrition, hormones, and lifestyle factors, and critically, it supports patients even without a formal diagnosis.</p><blockquote>“Just because you don’t have that label doesn’t mean we can’t start to address those symptoms.”</blockquote><p>Research shows there is often a two-to-five year window before a formal autoimmune diagnosis where the condition is already developing, and intervening during that window can meaningfully change the disease trajectory and reduce long-term costs.</p><p>One of the core challenges in autoimmune care is variability: no two patient journeys look the same. WellTheory’s solution is a rigorous, evidence-based clinical framework applied in a deeply personalized way, powered by registered dietitians, board-certified health coaches, and proprietary AI tools. Ellen described the role of health coaches as central to outcomes:</p><blockquote>“The health coaches are like behavior change experts, their job is to meet people where they are at. The goal is to help bridge the gap between knowing and doing, which is where outcomes actually come from.”</blockquote><p><strong>Business model and the shift to enterprise</strong></p><p>WellTheory started as a direct-to-consumer platform, intentionally building the patient experience first. The goal was always to make care affordable and accessible, but the path to doing so at scale ran through employers and health plans, who bear a disproportionate share of costs for this patient population. Autoimmune disease drives roughly 30% of overall pharmacy spend for a typical employer, and affected members can cost four to five times as much as the average member.</p><p>The direct-to-consumer phase served two critical functions: building an experience members genuinely loved, and generating an outcomes dataset rigorous enough to take into enterprise procurement conversations. Ellen engaged third-party actuaries early to build the business case. The transition hinged on demonstrating real patient demand and building a credible evidence base, and the result is a rare alignment in healthcare: improved patient outcomes, lower costs, and a viable business model.</p><p>The fundraising journey, however, was anything but easy. As a female founder building in women’s health, Ellen encountered skepticism about both the problem space and the business model. Her advice to other founders:</p><blockquote>“Treat fundraising like a sales process: map your stakeholders, be very deliberate about building momentum. Speed matters a lot more than people realize. The longer a raise goes on, the harder it gets.”</blockquote><p><strong>Autoimmune disease as a women’s health crisis</strong></p><p>The gender disparity in autoimmune disease is striking: roughly 80% of patients are women, and some conditions are 16 times more common in women. That insight has shaped WellTheory’s expansion into women’s health, with programs focused on hormonal conditions like PCOS, endometriosis, postpartum care, and menopause. Hormonal shifts at key life stages can trigger or worsen autoimmune conditions, connections that are consistently overlooked in traditional care models.</p><p>Ellen’s own experience is illustrative: she had a PCOS diagnosis before her autoimmune diagnosis, and no clinician ever connected the two. WellTheory’s postpartum program, recently launched, addresses a gap that traditional care has left almost entirely unaddressed. As Ellen explained:</p><blockquote>“What we’re trying to do differently is really provide continuous longitudinal care for members, where the person working with them through pregnancy is also staying with them through that postpartum transition.”</blockquote><p>This also resonates strongly with employers, who are increasingly focused on supporting women returning to work, yet have historically overlooked the autoimmune dimension of the postpartum experience.</p><p><strong>Advice for founders</strong></p><p>Ellen was candid about the weight of entrepreneurship. Her litmus test for aspiring founders is simple: are you staying up late thinking about this problem? She believes founders need to feel both uniquely qualified to solve it and deeply passionate about it, because companies, especially early on, are built by sheer grit and force of will.</p><p>She also touched on something rarely discussed: the importance of managing your own psychology as a founder.</p><blockquote>“There’s such an incredible amount of uncertainty in building an early-stage company. Whether it’s working with a therapist, a coach, or finding some outlet, managing your own mental health is such a critical part of it.”</blockquote><p>And for healthcare founders specifically, Ellen’s closing advice brings it back to first principles:</p><blockquote>“Always look for the win-win-win. If your solution only works for one party, it won’t scale. Zoom out and think about incentives, and instead of focusing on selling, focus on creating value that compounds across the whole ecosystem.”</blockquote><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=70411ea31c6a" width="1" height="1" alt=""><hr><p><a href="https://medium.com/wharton-pulse-podcast/ellen-rudolph-welltheory-on-rebuilding-autoimmune-care-70411ea31c6a">Ellen Rudolph, WellTheory, on rebuilding autoimmune care</a> was originally published in <a href="https://medium.com/wharton-pulse-podcast">The Pulse by Wharton Digital Health</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Lauren Makler, Cofertility, on Making Egg Freezing Accessible through Tech-Enabled Services]]></title>
            <link>https://medium.com/wharton-pulse-podcast/lauren-makler-cofertility-on-making-egg-freezing-accessible-through-tech-enabled-services-b1228af2d47a?source=rss----f7926dfebeed---4</link>
            <guid isPermaLink="false">https://medium.com/p/b1228af2d47a</guid>
            <category><![CDATA[womens-health]]></category>
            <category><![CDATA[fertility]]></category>
            <dc:creator><![CDATA[Chase Riley]]></dc:creator>
            <pubDate>Tue, 05 May 2026 13:01:06 GMT</pubDate>
            <atom:updated>2026-05-05T13:01:05.668Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/800/1*V2zai8TauGHhkvPnb-kh7g.png" /><figcaption>Lauren Makler, Co-founder &amp; CEO of Cofertility</figcaption></figure><p>In this episode of <em>The Pulse</em>, I sat down with <strong>Lauren Makler</strong>, co-founder and CEO of<a href="https://www.cofertility.com/"> Cofertility</a>, to talk about one of the most personal and overlooked challenges in women’s health: the cost and complexity of egg freezing and donation. Lauren’s career is a study in conviction — from launching Uber Health to channeling a deeply personal health journey into a company reshaping third-party reproduction in the U.S.</p><p>In our conversation, Lauren and I explored:</p><ul><li>Her path from Uber to healthcare entrepreneurship and the personal diagnosis that sparked Cofertility</li><li>Why existing egg freezing companies were making the problem worse, not better</li><li>How Cofertility’s Split model works and what makes it fundamentally different from traditional egg donation</li><li>Building a three-sided marketplace in a high-stakes, highly sensitive industry</li><li>How AI is changing the pace of product development at Cofertility</li><li>What Lauren looks for in the people she hires and what it really takes to thrive at an early-stage company</li></ul><p><strong>From Uber to Healthcare Entrepreneurship</strong></p><p>Lauren didn’t set out to build a fertility company. She studied at Northeastern, took her first job at an advertising agency, and following a mentor’s advice, <em>“if you’re going to work this hard, go to a startup and get a piece of the action,”</em> landed at Uber in 2013, when the company was in roughly 12 cities and had around 200 employees.</p><p>Her entry into healthcare came through an unexpected inbound: a support ticket from the Chief Innovation Officer of Boston Children’s Hospital at the time asking whether Uber could do something meaningful in health. Nobody else on Lauren’s team wanted it, so she took it on. That experiment led to her pitching Uber’s leadership in 2017 on Uber Health, which allowed healthcare organizations to order rides on behalf of low-income and elderly patients. The pitch was rejected more than once before it was finally approved.</p><p><em>“‘Just you wait’ is my motto. If I have conviction in something, trusting that has proven me well.”</em></p><p>Shortly after launching Uber Health, Lauren was diagnosed with a rare abdominal disease that put her ovaries at risk and forced her to confront egg donation firsthand. What she found shocked her: a space that felt antiquated, transactional, and unethical. Her sister donated her eggs as a backup ahead of Lauren’s surgeries. Three surgeries later, she kept her ovaries and had her first child without using her sister’s eggs, but the experience left a mark.</p><p><em>“I remember holding [my baby] in my arms and feeling like I had to run toward this feeling. I don’t want to spend my time doing anything other than helping other people have this feeling.”</em></p><p>At the end of 2021, Lauren connected with her now co-founder Halle Tecco, a longtime digital health pioneer who had been developing the concept of egg sharing, freezing your eggs for free in exchange for donating half. The timing felt right, and Cofertility was born.</p><p><strong>Why the Existing Egg Freezing Market Wasn’t Working</strong></p><p>By the time Cofertility launched, there were already companies trying to improve access to egg freezing. Lauren acknowledges the trail they blazed, but is also direct about where they fell short. The core problem is that existing solutions were making egg freezing more expensive, not less. The optimal window to freeze is in your 20s and early 30s, precisely when you’re least likely to have $15,000–$20,000 to spare. Adding another few thousand dollars to that cost doesn’t make the product better. It just prices out the people it’s supposed to help.</p><p>A pre-launch survey of nearly 1,000 women validated both the magnitude of the problem and the way they were trying to solve it. Over 90% of respondents said they wanted to freeze their eggs. Over 90% cited cost as the primary reason they hadn’t. And 66% said they’d be open to egg sharing if the system was reworked.</p><p><strong>How Cofertility is Rebuilding the Family Building Process</strong></p><p>Cofertility’s flagship “Split” program allows women ages 21–34 to freeze and store their eggs for free by donating half to intended parents. Its “Keep” program serves women who want to freeze their eggs without donating, connecting them with financing and storage partners. Both run on a proprietary three-sided matching platform connecting egg freezers, intended parents, and more than 225 fertility clinics across the U.S.</p><p>What sets Cofertility apart isn’t just the financing model, but how donation is structured. Traditional egg banks compensate donors up to $10,000 or more based on demographic factors like education, what Lauren calls <em>“surge pricing for egg donation.”</em> Cofertility charges all intended parents the same regardless of donor. The company offers what it calls disclosed donation as an option: most donors and intended parents choose to meet, exchange contact information, and in many cases stay in touch. And where a single donor at an egg bank might contribute eggs for up to 25 families, Cofertility caps its family limit at three.</p><p><em>“For the first time in history, we have enough donor-conceived people who are grown adults who can give their perspective about what it means to be donor-conceived. We’re building with them, for them.”</em></p><p>50% percent of Cofertility’s donors identify as women of color and the pool represents more than 55 ethnicities, which is central to why fertility clinics partner with them. When they refer an intended parent looking for a donor who reflects their background, they reliably find someone.</p><p><strong>Building the Platform and Why They Started Off the Shelf</strong></p><p>When Cofertility launched, Lauren and Halle deliberately held off on building proprietary technology immediately, using off-the-shelf egg donation software to prove product-market fit first. The platform handles donor screening, profile creation, and multi-stage matching funnels between donors and intended parents. Today, fertility clinics sit outside the platform by design; Cofertility sends reports directly to clinics rather than integrating with their EHRs, given how frequently fertility clinics switch software.</p><p>Lauren describes the business as a “tech-enabled service.” The emotionally laden nature of fertility means that every member interaction needs a real human on the other end and the technology exists to help that person move faster and manage more relationships at once.</p><p><strong>AI as a Booster Pack</strong></p><p>Lauren equates AI to a “booster pack” for builders, creating an ability to jump ahead in ways that companies before Cofertility never had, and that future companies will take for granted.</p><p>For example, Cofertility has long wanted to offer calculators to help members understand how many eggs to freeze based on their goals and help intended parents determine how many eggs they need. The logic existed, but building the tool never made it to the top of the tech team’s queue. With AI coding tools, non-technical team members can build those calculators in hours. <em>“Me, as a non-technical person, is coding. It’s the coolest thing.”</em></p><p>That mindset has gone company-wide. Cofertility’s cultural value of <em>“everything is figureoutable”</em> manifested this year as a vibe coding hackathon with every team member building solutions in Claude Code.<em> </em>She also acknowledges the guardrails a sensitive space like fertility requires. But her view on AI is unambiguous: if you’re not leaning in, you’re falling behind.</p><p><strong>What Lauren Looks for in the People She Hires</strong></p><p>Lauren’s hiring philosophy comes down to three things: obsession with the problem, willingness to do whatever it takes, and the power of persuasion.</p><p>The people who thrive on her team aren’t attached to any particular solution, instead, they’re fixated on the problem. She advises job seekers to apply the same filter and only pursue companies whose problems they genuinely care about. On grit, she’s a firm believer that it can’t be faked. And on persuasion, she wants people who can get on a call and convince anyone of anything.</p><p><strong>Looking Ahead</strong></p><p>For the first time in U.S. history, more women had children in their 40s than in their teens last year, a milestone made possible by IVF, egg donation, and egg freezing. That trend, in Lauren’s view, will only continue. The task now is to normalize it and make sure the infrastructure keeps pace with the demand.</p><p><em>“We need to normalize and destigmatize feelings around egg donation and third-party reproduction. This trend will only continue.”</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b1228af2d47a" width="1" height="1" alt=""><hr><p><a href="https://medium.com/wharton-pulse-podcast/lauren-makler-cofertility-on-making-egg-freezing-accessible-through-tech-enabled-services-b1228af2d47a">Lauren Makler, Cofertility, on Making Egg Freezing Accessible through Tech-Enabled Services</a> was originally published in <a href="https://medium.com/wharton-pulse-podcast">The Pulse by Wharton Digital Health</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Priyanka Jain, Evvy, on Using Biomarkers to Unlock Precision Women’s Health]]></title>
            <link>https://medium.com/wharton-pulse-podcast/priyanka-jain-evvy-on-using-biomarkers-to-unlock-precision-womens-health-926b2f627e5d?source=rss----f7926dfebeed---4</link>
            <guid isPermaLink="false">https://medium.com/p/926b2f627e5d</guid>
            <category><![CDATA[startup]]></category>
            <category><![CDATA[womens-health]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[precision-medicine]]></category>
            <category><![CDATA[digital-health]]></category>
            <dc:creator><![CDATA[Aneri Patel]]></dc:creator>
            <pubDate>Thu, 23 Apr 2026 00:21:39 GMT</pubDate>
            <atom:updated>2026-04-23T00:21:39.563Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/750/0*vNXvxPKiaerPfBR8.png" /><figcaption>Priyanka Jain, CEO and Co-Founder of Evvy</figcaption></figure><p>When I sat down with Priyanka Jain, CEO and co-founder of Evvy, it became clear that this company is much more than just testing. It’s built around a much bigger idea that women’s health has been held back for decades by a lack of data, and that if we want better outcomes, we first need better signals.</p><p>Evvy is tackling that challenge by starting with one of the most overlooked areas in medicine: the vaginal microbiome. While vaginal discomfort is one of the leading reasons women seek healthcare, it remains a space shaped by stigma, poor diagnostics, and treatments that too often miss the mark.</p><p>In our conversation, we explored Priyanka’s founding journey, why Evvy chose the vaginal microbiome as its starting point, how the company built trust with patients and providers, and what the future of precision women’s health could look like.</p><h3>A Personal Frustration That Turned Into a Startup Thesis</h3><p>Like many founders in women’s health, Priyanka’s journey started with personal frustration. She described experiencing mysterious health issues and bouncing from doctor to doctor without getting meaningful answers. Despite repeated tests and appointments, she kept hearing some version of the same thing: maybe you are stressed, maybe you should sleep more, maybe you should drink more water.</p><p>That experience pushed her to start doing her own research. She found that women were only required to be included in U.S. clinical research beginning in 1993, and even today, women are diagnosed later than men across hundreds of diseases. For Priyanka, that was the lightbulb moment.</p><blockquote>“This is actually a data problem fundamentally.”</blockquote><p>The female body is unique “right down to the cellular level,” yet the healthcare system still tracks and measures health largely according to signals derived from studying men. In other words, women’s bodies may be giving off important markers all the time, but we just have not spent enough time learning how to read them.</p><h3>Why Start with the Vaginal Microbiome?</h3><p>Evvy’s answer to that question is both practical and ambitious.</p><p>On the practical side, vaginal discomfort is incredibly common. Priyanka noted that it is one of the leading reasons women seek healthcare in America, yet women are more likely to be misdiagnosed than correctly diagnosed, and more likely not to get better than to get better.</p><blockquote>“When we go to the doctor, we are more likely to be misdiagnosed than correctly diagnosed. And we are more likely not to get better than to get better.”</blockquote><p>That alone would make this an important area to focus on. But what makes the vaginal microbiome especially compelling is its broader relevance across women’s health. Priyanka explained that disruptions in the vaginal microbiome can influence inflammation and infection throughout the reproductive tract, with implications for infertility, IVF failure, preterm birth, cervical cancer progression, menopause symptoms, STI acquisition, and more.</p><p>This is what makes Evvy’s work feel so much larger than a single diagnostic product. The company is treating the vaginal microbiome as a foundational biomarker. Evvy’s test is about finally being able to “turn on the lights” and see what is happening.</p><blockquote>“It’s the first time that you can actually turn on the lights and actually see what is happening in this really kind of critical set of biomarkers in your body.”</blockquote><h3>Building More Than a Test</h3><p>What Evvy has built is not just a test, but a platform.</p><p>The first layer is the metagenomics-based assay itself, which allows patients to collect a swab at home and sequence the bacteria and fungi in the sample. But the second layer is where Evvy becomes especially interesting, as the company combines that molecular data with what Priyanka called “the whole person.”</p><p>That means looking beyond the sample itself and asking:</p><ul><li>Is the patient in menopause?</li><li>Is she postpartum?</li><li>What birth control is she using?</li><li>What symptoms is she experiencing?</li></ul><p>From there, Evvy uses that information to predict the specific treatments or ingredients most likely to help that individual patient, and providers on the platform can prescribe more tailored care. That combination of biomarker discovery, real-world patient context, and individualized treatment pathways is what makes Evvy a precision health company.</p><h3>A Patient-Led Go-to-Market Strategy</h3><p>One of the most interesting parts of our discussion was Priyanka’s explanation of why Evvy started direct-to-consumer. Simply put, the people most motivated to change the system are patients themselves.</p><p>Doctors, she pointed out, are often not incentivized to learn an entirely new science or deliver a radically different care experience, especially in a system that rewards speed over complexity. Women, by contrast, are the ones living with the consequences of delayed diagnoses, recurring symptoms, and ineffective treatments. They are the ones most eager for a better solution now.</p><blockquote>“The people who don’t want to wait thirty years for a better solution, they want a better solution today.”</blockquote><p>That patient-first approach has also created a kind of demand flywheel. As women use Evvy and get answers, they bring those answers back to their clinicians. Over time, that patient demand has translated into provider interest and adoption. Priyanka shared that Evvy now works with over 100,000 patients and more than 2,000 practitioners across the country.</p><p>Priyanka notably doesn’t frame DTC as the end state. She frames it as a way to generate enough patient outcomes and real-world data to eventually bring in providers and, later, payers.</p><h3>Why Brand and Trust Matter So Much</h3><p>Another thread that came up repeatedly in our conversation was trust.</p><p>Priyanka said one of the biggest bets Evvy is making is on building a brand that is both scientifically rigorous and culturally relevant. The company did not want to be another “pink brand.” It wanted to speak to women in a way that felt smart, credible, and modern.</p><p>Priyanka described brand trust and data as a flywheel: women trust Evvy enough to use the platform, that usage creates more data, and that data then improves the care experience, which in turn deepens trust.</p><blockquote>“The reason we have the data is because we have consumer trust.”</blockquote><p>That idea feels especially important in a category where so many women have been dismissed, misunderstood, or made to feel that their symptoms are somehow too minor or too taboo to deserve serious attention.</p><h3>What the Future Could Look Like</h3><p>Looking ahead, Priyanka is excited about using Evvy’s growing dataset to validate that the vaginal microbiome may play a significant role across multiple areas of women’s health.</p><p>She mentioned active research across infertility, IVF failure, preterm birth, menopause symptoms, cervical cancer progression, and even the potential to help diagnose conditions like PCOS and endometriosis. The long-term vision is not just better vaginal health, but better women’s health outcomes more broadly, all beginning with one simple at-home swab.</p><p>When I asked her about AI’s impact on women’s health, rather than dismissing the fact that women are increasingly turning to AI tools for answers, Priyanka argued that the right response is to make those tools better and hold them to a higher standard, especially for women.</p><p>Women are already searching for answers. The task now is to build systems, datasets, and technologies that can actually serve them well.</p><h3>Closing Thoughts</h3><p>My biggest takeaway from this conversation is that Priyanka Jain is building Evvy with a very clear sense of what has been missing in women’s healthcare: the data and research infrastructure to drive outcome improvement.</p><p>Better outcomes in women’s health will come from better measurement, better data, better diagnostics, and better treatment pathways designed around women’s bodies.</p><p>There was one line from the conversation that felt especially fitting for me as an aspiring entrepreneur:</p><blockquote>“Every topic is learnable and every problem is solvable.”</blockquote><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=926b2f627e5d" width="1" height="1" alt=""><hr><p><a href="https://medium.com/wharton-pulse-podcast/priyanka-jain-evvy-on-using-biomarkers-to-unlock-precision-womens-health-926b2f627e5d">Priyanka Jain, Evvy, on Using Biomarkers to Unlock Precision Women’s Health</a> was originally published in <a href="https://medium.com/wharton-pulse-podcast">The Pulse by Wharton Digital Health</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Dr. Giovanni Colella, Vanna Health, on Reimagining Community-Based Care for Serious Mental Illness]]></title>
            <link>https://medium.com/wharton-pulse-podcast/dr-giovanni-colella-vanna-health-on-reimagining-community-based-care-for-serious-mental-illness-ade2f9843b76?source=rss----f7926dfebeed---4</link>
            <guid isPermaLink="false">https://medium.com/p/ade2f9843b76</guid>
            <category><![CDATA[entrepreneurship]]></category>
            <category><![CDATA[psychiatry]]></category>
            <category><![CDATA[serious-mental-illness]]></category>
            <category><![CDATA[behavioral-health]]></category>
            <dc:creator><![CDATA[Chase Riley]]></dc:creator>
            <pubDate>Wed, 11 Feb 2026 13:01:03 GMT</pubDate>
            <atom:updated>2026-02-11T13:01:02.916Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*QqnjswCu0UFiEDjJlcO7mw.jpeg" /><figcaption>Giovanni Colella, MD, Co-founder &amp; CEO of Vanna Health</figcaption></figure><p>In this episode of <em>The Pulse</em>, I had the opportunity to sit down with <strong>Giovanni Colella, MD</strong> — a psychiatrist and experienced healthcare entrepreneur — to discuss his journey from clinical care to company-building, and what it takes to design care models for healthcare’s most complex populations.</p><p>Over the past several decades, Giovanni has co-founded several influential healthcare companies, including RelayHealth (acquired by McKesson), Castlight Health, OODA Health (acquired by Cedar), Solara Health, and Brightline, focused on pediatric behavioral health. Today, he’s the co-founder and CEO of <a href="https://www.vanna.health/"><strong>Vanna Health</strong></a>, a company delivering community-based care to individuals with serious mental illness (SMI), primarily within Medicaid populations. His perspective is shaped by both deep clinical training and lived experience building and operating companies at the intersection of care delivery, administration, and technology.</p><p>In our conversation, Giovanni and I explored:</p><ul><li>His path from clinical psychiatry to healthcare entrepreneurship — and what ultimately brought him back to behavioral health</li><li>Lessons from building multiple healthcare companies before launching Vanna</li><li>How Vanna’s psychosocial rehabilitation model is designed around people, place, and purpose</li><li>What it takes to scale a high-touch, in-person care model within Medicaid</li><li>How technology and AI can support frontline care teams without replacing human judgement</li></ul><p><strong>From Psychiatry to Entrepreneurship and Back Again</strong></p><p>Unlike many physicians, Giovanni didn’t enter medicine with a lifelong dream of becoming a doctor. He initially studied mathematics and philosophy before choosing psychiatry early in medical school, a path he followed through residency and years of clinical practice.</p><p>His move toward entrepreneurship was catalyzed by something deeply personal: his father’s struggle with serious mental illness. That experience led Giovanni to believe that while clinical care matters, it often isn’t sufficient on its own — and that creating change at scale would require building new models, not just treating individual patients.</p><p>His early companies focused on structural challenges in healthcare, from patient-provider communication to claims and benefits infrastructure. Only later, after selling OODA Health, did Giovanni return fully to behavioral health, leading first to co-founding Brightline, and most recently Vanna Health.</p><p><strong>What Vanna Health Is Building</strong></p><p>Vanna Health serves individuals living with SMI, primarily within Medicaid — a population often marked by high utilization and inconsistent care due to systems that fail to meet people where they are.</p><p>Giovanni describes Vanna’s philosophy through the “four Ps”:</p><ul><li><strong>People</strong> — consistent, trusting relationships</li><li><strong>Place</strong> — somewhere to belong beyond a clinical appointment</li><li><strong>Purpose</strong> — vocational and social re-engagement</li><li><strong>Payment</strong> — a value-based model that aligns incentives</li></ul><p>Operationally, Vanna deploys a psychosocial rehabilitation model that pairs members with coaches — often peers or community health workers — who engage them in their homes and communities. These teams are closely supported by clinicians and nurses, with standardized protocols and clear escalation pathways.</p><p><em>“We’re not just an engagement engine. We’re a social rehabilitation engine — designed to help people stabilize their lives, not just show up to appointments.”</em></p><p>A core part of this approach is Vanna’s partnership with clubhouses, community spaces that allow members to participate in running daily operations — from cafés and art studios to transitional employment programs. Giovanni pointed to <a href="https://www.fountainhouse.org/">Fountain House</a> in New York as the archetype. Where traditional clubhouses don’t exist, Vanna builds “clubhouse-light” environments that provide members with somewhere to go, something to work toward, and people who know them. This emphasis on community shapes how Vanna enters new markets.</p><p><em>“You can’t parachute into a community and expect trust. You have to build relationships long before you ever enroll a member.”</em></p><p>Vanna partners with Medicaid health plans, identifies high-cost members using claims data, and takes on financial risk — earning revenue only if outcomes improve and total cost of care declines.</p><p><strong>Scaling a High-Touch Model in a Medicaid World</strong></p><p>Vanna first launched in Philadelphia, where early pilots showed reductions in cost and utilization. The company has since expanded into Arizona and Indiana, with plans to launch in New York.</p><p>Giovanni is candid about the challenge ahead: scaling an in-person, clinician-supported model is operationally complex and expensive — but a level of investment necessary to serve this population well.</p><p><em>“Medicaid forces you to be disciplined — the margins are tight, the needs are real, and the model either works or it doesn’t.”</em></p><p>While much of behavioral health has gravitated toward virtual-only care, Giovanni is skeptical that teletherapy alone can meet the needs of individuals with SMI. For this population, consistent in-person support is foundational.</p><p><strong>Technology as an Enabler in Behavioral Health</strong></p><p>Despite his background in health tech, Giovanni is clear that Vanna is a services company, though technology plays a critical role in enabling high-touch care at scale.</p><p>Vanna built its own internal platform, Vanna Connect, to reduce administrative burden and support care coordination. Giovanni noted that traditional case managers often spend more than half their time on paperwork and faxing. Vanna’s technology is designed to give that time back to frontline teams. The platform has been strong enough that one health plan licensed it independently, signaling that gaps in Medicaid care management infrastructure persist.</p><p>That services-first mindset also shapes how Giovanni thinks about AI. He sees AI as a powerful support tool — helping teams route cases appropriately and reduce cognitive load — but not as a replacement for human care.</p><p><em>“AI won’t replace human care for this population — but it can make the people doing the work far more effective.”</em></p><p><strong>Advice for Aspiring Healthcare Founders</strong></p><p>Giovanni closed with advice for MBA students and early-stage founders interested in healthcare:</p><ul><li>Be prepared for a long, iterative journey — progress comes from steady execution, not quick wins</li><li>Healthcare doesn’t behave like textbook markets; expect inefficiency, regulation, and long timelines</li><li>Build with humility and openness — the people closest to the problem will teach you more than any framework</li></ul><p>That guidance, he noted, applies whether you want to found a company or join one.</p><p>As Giovanni put it:</p><p><em>“If you’re serious about this space, you have to go see the work. Spend time with patients, spend time in the field — that’s how you learn if this is really for you.”</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=ade2f9843b76" width="1" height="1" alt=""><hr><p><a href="https://medium.com/wharton-pulse-podcast/dr-giovanni-colella-vanna-health-on-reimagining-community-based-care-for-serious-mental-illness-ade2f9843b76">Dr. Giovanni Colella, Vanna Health, on Reimagining Community-Based Care for Serious Mental Illness</a> was originally published in <a href="https://medium.com/wharton-pulse-podcast">The Pulse by Wharton Digital Health</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Rahul Naidoo, Superscript, on Rewriting the Rules of Healthcare Pricing]]></title>
            <link>https://medium.com/wharton-pulse-podcast/rahul-naidoo-superscript-on-rewriting-the-rules-of-healthcare-pricing-9b057416c32d?source=rss----f7926dfebeed---4</link>
            <guid isPermaLink="false">https://medium.com/p/9b057416c32d</guid>
            <category><![CDATA[startup]]></category>
            <category><![CDATA[healthcare-technology]]></category>
            <category><![CDATA[digital-health]]></category>
            <dc:creator><![CDATA[Sarah Healy]]></dc:creator>
            <pubDate>Wed, 04 Feb 2026 13:01:04 GMT</pubDate>
            <atom:updated>2026-02-05T14:28:13.122Z</atom:updated>
            <content:encoded><![CDATA[<p><em>🎧 Subscribe to The Pulse by Wharton Digital Health on </em><a href="https://podcasts.apple.com/us/podcast/the-pulse-by-wharton-digital-health/id1442422790"><em>Apple</em></a><em> and </em><a href="https://open.spotify.com/show/6c3GYfXasBWEDrMMJJ1NmA"><em>Spotify</em></a><em> for more conversations with the leaders reshaping the health tech landscape.</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/751/1*s_gUT_kCzH0fLoYr9cN-nw.jpeg" /><figcaption>Rahul Naidoo, co-founder and CEO of Superscript</figcaption></figure><p>In this episode of The Pulse Podcast, I sat down with Rahul Naidoo, co-founder and CEO of <strong>Superscript</strong>, an early-stage health tech company on a mission to redefine the financial experience in healthcare for both patients and providers.</p><p>Founded in 2021, Superscript spent nearly three years in R&amp;D building what Rahul calls “healthcare’s first pricing protocol” — technology that turns surprise, after-the-fact medical bills into <strong>clear, upfront prices</strong>. The company now works with nearly 300 providers across New York, New Jersey, and Texas, has empowered close to 50,000 patients with upfront prices, and is backed by investors including Mark Cuban, early backers of Uber and SpaceX, and founders from Dropbox and Everly Health.</p><p>Rahul and I talked about his unconventional journey from Cape Town to Harvard to health tech founder, why he believes <strong>consumer-style pricing is the missing backbone of U.S. healthcare</strong>, and how Superscript is betting on a radically different approach to pricing transparency — one that doesn’t just “estimate” costs, but actually <strong>takes on financial risk</strong> to guarantee them.</p><h3>First-Time Founder on Taking the Leap</h3><p>Rahul grew up in Cape Town, South Africa, and came to the U.S. to study computer science at Harvard. Unlike many of his classmates, he never bought into the traditional idea of a “career.” While friends lined up banking and consulting internships, Rahul resisted recruiting altogether. After graduation, that decision caught up with him, and he ultimately joined <strong>Roivant Sciences</strong> on a digital product team tasked with spinning internal tech into standalone startups. Within weeks, that team itself spun out as <strong>Lokavant</strong>, a clinical trial data company.</p><p>At Lokavant, Rahul learned what it really means to build from scratch: standardizing messy data sets, shipping tools for clinical researchers, and watching how startup incentives collide and intertwine with those of a large parent company. But after a couple of years, something hadn’t changed: his instinctive aversion to a traditional job. In August 2021, he left Lokavant and, with one of his closest friends from college, Rit Chakraborty, they started brainstorming ideas to reach their ultimate goal to <strong>build something worth building</strong>.</p><p>What finally changed wasn’t the perfect idea. It was <strong>risk</strong>.</p><blockquote>There’s no substitute for real risk. The garage project, side-hobby model doesn’t really work. At some point, you just have to jump off the cliff and build the plane on the way down.</blockquote><p>They changed their LinkedIn bios to “building something in stealth”, and then they started actually talking to the healthcare system. The early team grew from there, and Superscript was officially born.</p><h3>From Theory to Action, and Why You Can’t “Game” Startups</h3><p>Rahul describes his biggest personal growth area as the shift from <strong>highly theoretical</strong> to <strong>deeply applied</strong>. At the beginning of Superscript, he was inclined to respond to every problem with a long, philosophical write-up: how one <em>ought</em> to deploy customers, design products, or run operations in an ideal world. Superscript was built on first-principles thinking — which Rahul still believes is essential. But he learned the hard way that <strong>staying in theory is its own kind of trap</strong>.</p><p>The second big learning was realizing that you <strong>can’t gamify company-building</strong> the way you can exams, recruiting, or student competitions. Growing up in structured systems like school, Rahul found the shortcut: figure out the rubric, optimize for what evaluators want, and you’ll win. That mindset can even carry you through early parts of startup life, especially fundraising, where a good narrative might temporarily outpace your actual product. But, as he put it, quoting Jeff Bezos, “In the long run, the market is a weighing machine.”</p><blockquote>You might be able to game your way through one or two rounds. But at some point the market asks, ‘Are you creating real value?’ And there’s no way to fake that.</blockquote><p>For him, building Superscript has been a lesson in <strong>radical realism and authenticity</strong>: making sure the story, the spreadsheets, and the user experience all reflect something <em>real</em>.</p><h3>Building “Healthcare’s First Pricing Protocol”</h3><p>When Rahul and his co-founder looked at U.S. healthcare with fresh eyes (and almost no “traditional” healthcare experience), one thing jumped out immediately:</p><p>Healthcare is the <strong>only major consumer-facing category that doesn’t actually function like one.</strong></p><p>In every other industry, consumers can wake up, see a price, click a buy button, and know exactly what they’re going to pay. That simple “proactive buying motion” — prices + choice + action — is the backbone of all consumer markets.</p><p>In healthcare, it’s almost entirely missing, and the consequences are everywhere, ranging from wild price variation, to sky-high U.S. spending, to terrible patient experiences. Rahul shared his core belief: <strong>if you can restore a true consumer purchasing motion to healthcare, you can start to fix both pricing and experience from the ground up.</strong></p><p>Superscript’s first ambition was bold: become the <strong>Amazon of healthcare — </strong>a marketplace where consumers could shop across providers and treatments with clear, upfront prices. They quickly realized that to do that credibly, they’d first need something more fundamental: <strong>a way to generate prices that don’t currently exist. </strong>Contrary to the common assumption that prices are “known but hidden,” Rahul explains that, structurally, <strong>healthcare prices aren’t really computed until after care is delivered.</strong></p><p>The current process looks like this:</p><ol><li>You get care.</li><li>A biller converts your clinical notes into a claim using a combination of codes (CPT, modifiers, etc.).</li><li>Your insurer attaches internal rates to each code, sums them, and then applies your specific benefits to determine your cost-share (copay, coinsurance, etc.) relative to theirs.</li><li>Only then does a patient-facing number appear — which becomes the bill you get weeks later.</li></ol><p>Superscript’s answer is the <strong>pricing protocol</strong>, a stack of two engines that together produce a <em>deterministic</em> patient price <em>before</em> care happens. The result: <strong>for every service, across every insurance plan, Superscript can generate a single, stable patient price upfront</strong> — the same number that would otherwise have shown up on a bill weeks later. That price is then displayed on platforms built by Superscript — consumer facing websites, and a practice-facing tool for the front desk. Once the patient pays, they’re done. No surprise bill in the mail. No chasing. No mystery.</p><h3>Why Providers Care: Capturing Lost Patient Revenue</h3><p>Superscript was originally built with consumers in mind. But as the team brought their technology into the real world, they discovered it also solves a <strong>significant problem for providers</strong>. Under the status quo, practices miss somewhere between <strong>20–60% of patient payments</strong> they’re technically owed. Patients move on, feel blindsided by bills, or simply choose not to pay.</p><p>If practices can’t quote accurate prices upfront, they can’t have meaningful financial conversations with patients, or reliably collect the money they’re owed. By enabling practices to price every service upfront and take payment before the visit–while still respecting insurance benefits–Superscript turns previously lost dollars into <strong>real, collected revenue</strong>. For many practices, patient payments represent 20–40% (and sometimes more) of total revenue, so leakage here is existential.</p><p>Superscript’s long-term vision still includes the marketplace. For now, they’re in <strong>Phase 1</strong>: deploy pricing technology broadly across practices, build a robust supply network, and then someday turn those pipes outward toward consumers.</p><h3>The Biggest Misconception About Healthcare Prices</h3><p>Ask most people what’s wrong with healthcare pricing and you’ll hear some version of: <strong>“The prices are there — the system just doesn’t want us to see them.”</strong></p><p>Rahul thinks that framing is incomplete.</p><blockquote>The truth is more frustrating. Prices don’t exist in a consumer-friendly way at all. What exists is a giant, messy pile of building blocks.</blockquote><p>When hospitals were required to publish rates data in 2021, the result didn’t look like a menu of services with prices. It looked like hundreds of thousands of service codes, each with multiple potential rates, none of which directly reflect what <em>you</em>, as a specific patient on a specific plan, will pay. To turn that into “your price,” you’d essentially have to replicate what Superscript’s pricing protocol does: anticipate which codes will apply, identify the associated rate, sum them, and then correctly apply your unique plan rules.</p><p>In other words, the problem isn’t just that prices are <strong>hidden</strong>. It’s that they’re <strong>never available in a consumer-friendly format</strong> — until it’s too late to decide.</p><h3>Why Superscript Thinks It Can Win</h3><p>When I asked Rahul why he believes Superscript will succeed where other pricing transparency efforts have struggled, he pointed to two things:</p><ol><li><strong>A radically different bar for what “pricing” even means.<br></strong> Most of the industry has focused on speed (“real-time adjudication”) or <strong>estimates</strong> (“your CT scan may cost $50–$600”). Superscript insists that <strong>real prices</strong> — numbers you can actually buy against — are the only thing that will change behavior. That decision forced them to treat pricing as a <strong>financial problem</strong>, not just a data or transparency problem — and to be willing to assume risk when their estimates and reality don’t match.</li></ol><blockquote>We decided not to play the estimates game. We wanted prices that are as actionable as any other consumer category.</blockquote><ol><li><strong>The team’s belief-driven motivation.<br></strong> Rahul describes Superscript’s team as unusually mission-aligned. He’s convinced that if you maintain that level of intensity and alignment over a long enough period, “victory is almost inevitable.”</li></ol><blockquote>No one here is just doing a job or pushing spreadsheets. People are here because they believe something about how healthcare should work.</blockquote><p>I left this conversation energized by Rahul’s combination of philosophical depth and practical intensity — and by Superscript’s willingness to tackle one of the gnarliest parts of U.S. healthcare with both <strong>financial rigor</strong> and <strong>consumer empathy</strong>. If Superscript can make upfront prices real in healthcare — not just estimates — it could unlock a wave of consumer behavior, market discipline, and practice sustainability that we haven’t yet seen in this space. I’m excited to follow how Rahul and the Superscript team continue to build, and how their work might reshape how all of us experience the cost of care.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=9b057416c32d" width="1" height="1" alt=""><hr><p><a href="https://medium.com/wharton-pulse-podcast/rahul-naidoo-superscript-on-rewriting-the-rules-of-healthcare-pricing-9b057416c32d">Rahul Naidoo, Superscript, on Rewriting the Rules of Healthcare Pricing</a> was originally published in <a href="https://medium.com/wharton-pulse-podcast">The Pulse by Wharton Digital Health</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Jake Sussman, Marble Health, on Building a School-Centered Model to Address the Youth Mental Health…]]></title>
            <link>https://medium.com/wharton-pulse-podcast/jake-sussman-marble-health-on-building-a-school-centered-model-to-address-the-youth-mental-health-c9f4a456dee1?source=rss----f7926dfebeed---4</link>
            <guid isPermaLink="false">https://medium.com/p/c9f4a456dee1</guid>
            <dc:creator><![CDATA[Chase Riley]]></dc:creator>
            <pubDate>Tue, 20 Jan 2026 13:03:25 GMT</pubDate>
            <atom:updated>2026-01-20T13:03:24.432Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/800/1*VN7r1HQnkK2VfDKYGNhCyQ.jpeg" /><figcaption>Jake Sussman, co-founder &amp; CEO of Marble Health</figcaption></figure><h3><strong>Jake Sussman, Marble Health, on Building a School-Centered Model to Address the Youth Mental Health Crisis</strong></h3><p>In this episode, I had the pleasure of sitting down with <strong>Jake Sussman</strong>, co-founder and CEO of <a href="https://www.marblehealth.com/"><strong>Marble Health</strong></a>, a company building a new model of mental health care for children and teens. Jake shared why the youth mental health crisis demands a fundamentally different approach than adult care — and how Marble is using schools, insurance-aligned incentives, and thoughtfully applied technology to expand access.</p><p>Founded in 2023, Marble delivers virtual therapy for students, offering both one-on-one and group sessions with no waitlists and appointments available in as little as four days. In its first 15 months, Marble scaled from zero to millions in revenue, with more than half of the children it serves covered by Medicaid. The company recently raised a $15.5M Series A to expand its school-based model nationwide.</p><p>In our conversation, Jake and I explored:</p><ul><li>His path from Headway to the classroom — and ultimately to Marble</li><li>Why access, not treatment quality, is the core issue in youth mental health</li><li>How school counselors became Marble’s entry point to care</li><li>How Marble delivers no-waitlist care amid a clinician shortage</li><li>How Marble uses technology and AI to support collaboration, not replace clinicians</li></ul><p><strong>From Platform Builder to the Front Lines of Youth Mental Health</strong></p><p>Jake’s connection to mental health started early. He’s the son of a therapist and a psychiatrist and experienced firsthand how difficult it can be to find affordable, in-network care, which helped inspire the first company he co-founded, Headway.</p><p>After helping scale one of the fastest-growing platforms in mental health, Jake made an unexpected pivot into teaching at Success Academy in New York City — an experience that would go on to shape Marble’s model in a fundamental way.</p><p><em>“I didn’t realize before teaching how much school counselors had been pushed into a clinical role. Kids were showing up with depression, anxiety, suicidality and counselors were expected to manage it with almost no resources.”</em></p><p>That insight became foundational to Marble. School counselors, Jake realized, were already the front door to youth mental health — they just lacked the infrastructure to connect students to timely, effective care.</p><p><strong>Where the Youth Mental Health System Breaks Down</strong></p><p>While evidence-based treatments for anxiety and depression are well established, access remains the core challenge, especially for kids. School counselors field daily requests for help but are often forced to refer families to overburdened community clinics with months-long waitlists. Private practice therapists, meanwhile, face administrative barriers that limit their ability to serve adolescents.</p><p><em>“Everyone wants the same thing. School counselors, therapists, insurers, families — they all benefit when kids get into care early. But none of them can solve the problem on their own.”</em></p><p>Marble’s strategy was to build the connective tissue between these stakeholders.</p><p><strong>Marble’s Mission to Connect Schools, Therapists, and Health Plans</strong></p><p>Marble contracts with insurers to become an in-network youth mental health provider, aggregates a network of therapists who accept both commercial and Medicaid plans, and makes that capacity immediately available to schools — at no cost to the school counselor.</p><p>With a referral that takes less than 30 seconds, counselors can connect students to care with no waitlists. Just as importantly, Marble closes the loop: counselors can see where a student is in their care journey and collaborate directly with therapists.</p><p>Marble’s model reflects the realities of youth mental health, which requires close coordination among parents, school counselors, and clinicians. Therapy is delivered after school and on weekends to avoid disrupting academics, guardians play an active role in care decisions, and Marble’s platform enables ongoing collaboration so care doesn’t happen in isolation.</p><p><em>“Collaborative care isn’t just nice to have for kids. It’s predictive of better outcomes.”</em></p><p>Marble first launched in New York and is now expanding into New Jersey and Ohio, prioritizing large markets with manageable Medicaid complexity and strong reimbursement environments. Over time, the company plans to operate nationally.</p><p><strong>Using Technology to Reduce Friction Across Youth Mental Health</strong></p><p>Marble has built its own EHR and operational tooling to make insurance, including Medicaid, “magically easy” for therapists and referrals frictionless for schools.</p><p>The company is actively investing in AI as a way to meaningfully improve care quality, not just increase efficiency. The team has already built its own AI scribe, which has listened to thousands of therapy sessions and automatically proposes progress notes to reduce administrative burden for clinicians. Over time, that scribe has become something more important: a quality wedge. By having visibility into what actually happens during sessions, Marble can continuously evaluate and curate its clinical network, even as it scales to hundreds of thousands of appointments.</p><p>That same foundation is now powering the next phase of Marble’s product roadmap. They are currently building an AI-powered patient companion that engages students between sessions, reinforcing progress and providing support when it’s needed most. Because the companion listens during therapy appointments, it can interact with patients in a highly personalized and context-aware way in the days between visits, while always keeping human clinicians in the loop.</p><p><em>“Our view is that AI should amplify human care, not replace it. Especially when you’re working with kids.”</em></p><p><strong>Staying Connected with Marble</strong></p><p>Marble is still early in its journey — “the first inning,” as Jake put it — and team building remains the company’s top priority. Jake encourages mission-driven operators, clinicians, and students interested in youth mental health to reach out, even if there isn’t an obvious open role.</p><p><em>“The company you build is the team you build. That’s been true everywhere I’ve worked, and it’s especially true here.”</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=c9f4a456dee1" width="1" height="1" alt=""><hr><p><a href="https://medium.com/wharton-pulse-podcast/jake-sussman-marble-health-on-building-a-school-centered-model-to-address-the-youth-mental-health-c9f4a456dee1">Jake Sussman, Marble Health, on Building a School-Centered Model to Address the Youth Mental Health…</a> was originally published in <a href="https://medium.com/wharton-pulse-podcast">The Pulse by Wharton Digital Health</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Felicity Yost, Tia, on Designing a Healthcare System Women Actually Want to Use]]></title>
            <link>https://medium.com/wharton-pulse-podcast/felicity-yost-tia-on-designing-a-healthcare-system-women-actually-want-to-use-e06c7bcf9efc?source=rss----f7926dfebeed---4</link>
            <guid isPermaLink="false">https://medium.com/p/e06c7bcf9efc</guid>
            <category><![CDATA[womens-health]]></category>
            <category><![CDATA[female-entrepreneurs]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[entrepreneurship]]></category>
            <category><![CDATA[digital-health]]></category>
            <dc:creator><![CDATA[Aneri Patel]]></dc:creator>
            <pubDate>Thu, 08 Jan 2026 10:32:50 GMT</pubDate>
            <atom:updated>2026-01-08T10:32:49.993Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*lJacMNTAv-nXkb1AuD2cOg.png" /></figure><p>In this episode, I had the pleasure of sitting down with Felicity Yost, Co-Founder and CEO of Tia and one of the leading voices in women’s health.</p><p>Tia is a modern women’s health company that combines virtual and in-person clinics to deliver integrated, whole-body care for women, spanning primary care, gynecology, mental health, fertility, perimenopause and menopause, and more. Founded in 2017, Tia has raised roughly $150 million in funding from leading investors, as it scales a “whole-woman, whole-life” care model across markets in New York, California, and Arizona with plans to open more this year.</p><p>Felicity brings a deeply analytical and product-oriented perspective to healthcare. Before co-founding Tia, she worked at Bridgewater Associates and Owler, where she honed her expertise in high-velocity product execution.</p><p>In our conversation, Felicity and I explored:</p><ul><li>How her personal experiences shaped her passion to co-found Tia</li><li>How Tia redesigned women’s care around concerns, not specialties</li><li>Why the consumerization of care may be doing more harm than good</li><li>What it really takes to build sustainable healthcare businesses and teams</li><li>Her long-term bets on AI and preventive care</li></ul><h3><strong>How Passion and Pain Drove Felicity to Co-Found Tia</strong></h3><p>Felicity’s journey started with lived experience and, most notably, frustration. Felicity’s mother passed away from breast cancer when she was still in high school. Around the same time, her aunt was also diagnosed. As a teenager, Felicity began asking doctors pointed questions about cancer risk, prevention, and how reproductive health decisions might affect long-term outcomes.</p><p>The response was dismissive.</p><blockquote>“They basically laughed me out of the room… it didn’t feel data-driven or thoughtful about how the body actually works as an interconnected system.”</blockquote><p>Years later, after being diagnosed with rheumatoid arthritis post-college, the pattern repeated. She was bounced between specialists, shut down for asking questions about how medications might affect her reproductive health, and left without a clear, holistic care plan.</p><p>These experiences revealed something fundamental: modern healthcare systems and medical research were built around a “male default,” and that has led to real gaps in care for women.</p><blockquote>“I still have not met a single woman who doesn’t have a bad healthcare story.”</blockquote><h3><strong>How Primary Care at Tia Is Reimagined Around Concerns, Not Specialties</strong></h3><p>It became quickly evident to me that, at its core, Tia challenges the way modern medicine is organized. Traditional healthcare is built around specialties — primary care, gynecology, dermatology, mental health — each operating in its own silo. Women are expected to bounce around between them. Tia flips that model. Instead of asking “Which doctor do you need?”, Tia starts with “What are you experiencing?”</p><blockquote>“We design around a patient’s symptoms and care needs, not around the way the medical system has broken specialties into boxes.”</blockquote><p><strong>The Tia Care Model: Designed for Continuity</strong></p><p>For those who are unfamiliar, Tia integrates primary care, gynecology, mental health, dermatology, and wellness into a single, coordinated experience delivered through both physical clinics and virtual care.</p><p>Key components include:</p><ul><li>Unified medical records across all providers</li><li>Collaborative care teams who actively communicate with one another</li><li>Hybrid care journeys intentionally designed to include both in-person and virtual touchpoints</li></ul><p>One of the most critical pieces of the experience is onboarding, especially because Tia serves what Felicity calls a “medical orphan” population. Over 90% of Tia’s patients have not had an established primary care relationship before coming to Tia. Given that reality, Tia treats intake and onboarding as a clinical foundation, not an administrative hurdle. The onboarding process includes a comprehensive pre-visit intake form completed at home, a whole health exam (which includes a full-body physical exam, blood panels, ultrasounds if needed), and detailed lab review and follow-up.</p><blockquote>“For many patients, it’s the first truly comprehensive baseline they’ve ever had.”</blockquote><p><strong>An Example: Meeting Women Where They Are with Tia’s Hormone &amp; Vitality Assessment</strong></p><p>I then dove into one of Tia’s newest offerings, the Hormone &amp; Vitality Assessment. It was born from a simple but common patient refrain: “I just don’t feel like myself.”</p><p>Women in their 30s and 40s often experience changes in mood, sleep, weight, and energy, but are frequently misdiagnosed or prematurely labeled as perimenopausal. Tia designed this assessment to widen the diagnostic lens. Rather than jumping to conclusions, the assessment creates a structured process to explore root causes (whether hormonal, autoimmune, metabolic, or otherwise), while re-engaging women in preventive care during a period when many fall out of the system.</p><h3><strong>How Increasing Consumerization of Care May Be Doing More Harm Than Good</strong></h3><p>According to recent data by KFF, nearly half of adults under 30 in the U.S. do not have a primary care provider, a trend that has serious implications for long-term health outcomes. When I asked Felicity what’s the driving force behind this, she hypothesized that it was the result of two overlapping forces: increased mobility in young adults and the increasing consumerization of care.</p><blockquote>“Care has become incredibly episodic.”</blockquote><p>First, younger adults are far more geographically mobile than previous generations. People move cities for school, work, or relationships every few years, making it difficult to establish and maintain long-term provider relationships.</p><p>Secondly, as medical care becomes increasingly consumerized (from on-demand prescriptions, one-off telehealth visits, direct-to-consumer testing, etc.), care shifts from relationship-based to transactional. In this model, patients are rewarded for speed and convenience, not continuity, and there becomes little incentive to establish a primary care provider when immediate needs can be solved in isolation. Tia’s model intentionally resists this fragmentation by emphasizing provider relationships, unified records, and repeat engagement over one-off transactions.</p><h3><strong>Building sustainable business models and team models in healthcare</strong></h3><p>Felicity is unapologetic about the fact that building healthcare the “right way” is slower.</p><blockquote>“If we don’t do it right, we’re not actually solving the problem. And then what’s the point? Why do any of it if we’re not actually making women healthier?”</blockquote><p>Tia’s commitment to brick-and-mortar clinics, health system partnerships, and complex care coordination means it is not likely to scale like a pure software company or a standard telehealth model. That requires a specific kind of investor and board member alignment — people who understand Tia’s not going to move as fast as other digital health companies. These are also individuals who understand that Tia’s main OKR is achieving profitability <em>without</em> compromising clinical outcomes.</p><p>With Felicity’s background in product management, she treats Tia’s entire clinical strategy from the technology to care delivery as a product to be optimized around real user needs. Teams are structured that way too. For example, one of the most distinctive decisions Tia made was creating a Clinical Strategy &amp; Innovation (CSI) role inside the product organization. This role thinks horizontally across patient, provider, and admin experiences to make sure that each stakeholder’s perspectives in the care experience are considered.</p><blockquote>“Instead of optimizing one guide process or specialty, we slice across the entire care experience from the end user’s perspective.”</blockquote><p>The result is a deeply cross-functional organization. It may be harder to manage and slower at times, but it’s ultimately been more cohesive for patients.</p><h3><strong>Felicity’s long-term bets on AI and preventive care</strong></h3><p>Lastly, I asked Felicity about the future of AI in guiding women’s health outcomes. She shared that she’s most excited by the promise of AI not as a replacement for doctors, but as a tool to better guide patient decision-making. Specifically, she highlighted the need for a precision-medicine backend powered by personalized, longitudinal data — ranging from family history to a patient’s most recent biometrics and bloodwork.</p><blockquote>“People are really trying to answer one question: should I go to the doctor or not?”</blockquote><p>She highlights that AI is most powerful when paired with user trust, an accurate context, and real clinical data, not when operating in isolation. The open question in her mind was which company would be the first to try and the first that users trust.</p><p>However, her biggest bet remains unchanged. Preventive care is the transformational lever.</p><blockquote>“Getting women to engage in care repeatedly, over decades, is what will ultimately improve outcomes — and unlock better clinical protocols for the future.”</blockquote><h3><strong>Final Thoughts</strong></h3><p>Tia’s story is not about disruption for disruption’s sake. It’s about rebuilding trust — between women and their bodies, between women and their providers, and ultimately between women and the healthcare system meant to serve them.</p><p>There’s been increasing discussion about the need for greater ecosystem collaboration in women’s health, and it’s clear that companies like Tia are open to (and actively pushing for) those conversations. Progress in this space won’t come from isolated solutions, but from ecosystem players that are willing to integrate, partner, and prioritize continuity over competition.</p><p>Lastly, over the past year, much of the industry has rightly focused on the impact of AI. But in that focus, we risk overlooking what may be the true table stakes: getting women back into consistent, preventive care. Without that foundation, even the most advanced innovations in wearables, remote diagnostics, hormone intelligence, and care navigation risk falling short of meaningfully improving women’s health outcomes.</p><p><em>🎧 Subscribe to The Pulse by Wharton Digital Health on </em><a href="https://podcasts.apple.com/us/podcast/the-pulse-by-wharton-digital-health/id1442422790"><em>Apple</em></a><em> and </em><a href="https://open.spotify.com/show/6c3GYfXasBWEDrMMJJ1NmA"><em>Spotify</em></a><em> for more conversations with the leaders reshaping the health tech landscape.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=e06c7bcf9efc" width="1" height="1" alt=""><hr><p><a href="https://medium.com/wharton-pulse-podcast/felicity-yost-tia-on-designing-a-healthcare-system-women-actually-want-to-use-e06c7bcf9efc">Felicity Yost, Tia, on Designing a Healthcare System Women Actually Want to Use</a> was originally published in <a href="https://medium.com/wharton-pulse-podcast">The Pulse by Wharton Digital Health</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Samir Malik, firsthand, on Building Trust-First Care for Serious Mental Illness]]></title>
            <link>https://medium.com/wharton-pulse-podcast/samir-malik-firsthand-on-building-trust-first-care-for-serious-mental-illness-220584d24dc5?source=rss----f7926dfebeed---4</link>
            <guid isPermaLink="false">https://medium.com/p/220584d24dc5</guid>
            <category><![CDATA[value-based-care]]></category>
            <category><![CDATA[behavioral-health]]></category>
            <category><![CDATA[peer-support]]></category>
            <category><![CDATA[serious-mental-illness]]></category>
            <category><![CDATA[medicaid]]></category>
            <dc:creator><![CDATA[Chase Riley]]></dc:creator>
            <pubDate>Tue, 16 Dec 2025 13:02:25 GMT</pubDate>
            <atom:updated>2025-12-16T13:02:24.956Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/800/1*o_4kOTwWw-owjE7GPaEvQQ.jpeg" /><figcaption>Samir Malik, founder of firsthand</figcaption></figure><p>In our latest episode of The Pulse, I sat down with <strong>Samir Malik</strong>, founder of <a href="https://www.firsthandcares.com/"><strong>firsthand</strong></a>, a company pioneering a trust-first, peer-led model to reach individuals whom the traditional behavioral health system has failed to reach. Samir shared powerful insights on why trust is the missing ingredient in serious mental illness (SMI) care and how firsthand is rebuilding it through lived experience, community-based engagement, and value-based partnerships.</p><p>In our conversation, Samir and I explored:</p><ul><li>His path into behavioral health and the origins of firsthand</li><li>Why SMI requires a different approach than traditional clinical models</li><li>How firsthand’s peer-led model engages individuals the system has struggled to reach</li><li>firsthand’s value-based partnerships with Medicaid Managed Care Organizations (MCOs)</li><li>The role technology plays in enabling high-touch, trust-first care</li></ul><p><strong>Samir’s Path to Behavioral Health and the Origins of firsthand</strong></p><p>After studying at Wharton as an undergrad, Samir joined McKinsey, where analyzing early drafts of the Affordable Care Act first sparked his interest in healthcare. He later worked at a psychiatric hospital in St. Louis, where he saw the realities of behavioral health up close: outdated, paper-based systems, limited outpatient support, and individuals repeatedly cycling in and out of crisis.</p><p>Motivated to expand access to care, Samir returned to Wharton for his MBA and began building 1DocWay during his time in the Healthcare Management program, refining the concept through coursework, faculty mentorship, and the Venture Initiation Program. 1DocWay was later acquired by Genoa Healthcare and then by Optum, where the telepsychiatry platform ultimately grew into the largest in the country.</p><p>Across these experiences, Samir saw the same theme: individuals with behavioral health conditions weren’t engaging in care, not because treatment was ineffective, but because trust had been broken. That insight inspired the idea behind firsthand: a model built to meet individuals where they are and rebuild trust through lived experience.</p><p><strong>Why SMI Requires a Different Approach</strong></p><p>Samir explained that while treatments for schizophrenia, bipolar disorder, and major depressive disorder are well studied and effective, access remains a major barrier. Many individuals with SMI interact with the healthcare system only during acute crises, often involving police encounters, ER visits, or involuntary psychiatric holds.</p><p><em>“The challenge today isn’t the quality of treatment — it’s that far too few people who need these services are accessing them.”</em></p><p>These crisis-driven interactions erode trust, making it difficult for individuals to stay engaged long enough to benefit from care. Samir emphasized that any model hoping to improve outcomes must first repair trust, which is the foundation of firsthand.</p><p><strong>Inside firsthand: A Peer-Led, Trust-First Model</strong></p><p>firsthand’s care model centers on peer support — individuals with lived experience with SMI or substance use. Peers build trust in ways that traditional care teams often cannot. They knock on doors, meet people where they are, and help navigate both clinical and social needs: medication access, housing, benefits, family dynamics, transportation, and more.</p><p><em>“If we’re going to build trust, we have to come from a place of lived experience.”</em></p><p>firsthand currently operates in Washington, Florida, Virginia, Ohio, and Michigan, expanding into new markets in partnership with Medicaid MCOs who identify regions with significant unmet behavioral health need.</p><p><strong>A Value-Based Partnership Model Built on Outcomes</strong></p><p>firsthand works with Medicaid MCOs through value-based arrangements tied to total cost-of-care improvements. As individuals engage consistently with peers and stabilize clinically and socially, health plans see meaningful reductions in avoidable utilization.</p><p>Across markets, firsthand typically observes:</p><ul><li>~15% reduction in all-cause inpatient and ER utilization by month nine</li><li>30–40% reduction in inpatient psychiatric admissions</li><li>Increased outpatient engagement as individuals connect to ongoing care</li></ul><p>These improvements allow firsthand and its partners to structure models that reward measurable impact and long-term stability.</p><p><em>“To build a durable business, it has to be a good deal for everyone involved — the health plan, the individual, and us.”</em></p><p><strong>Technology’s Role: Enabling Human Connection at Scale</strong></p><p>While firsthand is rooted in in-person relationships, technology plays a critical supporting role. The company uses data science to risk-stratify populations, prioritize outreach, and guide peers toward the “next best action” for the individuals they support. firsthand’s technology is designed to reduce burden, not replace human connection, and ensure peers spend their time where it matters most.</p><p><em>“Tech that abstracts away the non-top-of-license work means we deliver more outcomes for more folks at a higher quality.”</em></p><p>Samir also sees potential for emerging technologies, including AI, to help the broader healthcare system better direct resources toward the highest-impact interventions if deployed thoughtfully and in service of individuals.</p><p><strong>How to Follow and Support firsthand</strong></p><p>For those inspired by firsthand’s mission, Samir encourages reaching out, especially students and operators interested in behavioral health, community-based care, or value-based models. Several Wharton alumni have already played key roles across firsthand’s operations, clinical strategy, and product organization.</p><p>More broadly, Samir encourages early-career leaders to think intentionally about where they apply their talent in healthcare.</p><p><em>“There’s so much good work that needs to be done in healthcare. Being thoughtful about where you spend your time and talent is what will pay dividends.”</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=220584d24dc5" width="1" height="1" alt=""><hr><p><a href="https://medium.com/wharton-pulse-podcast/samir-malik-firsthand-on-building-trust-first-care-for-serious-mental-illness-220584d24dc5">Samir Malik, firsthand, on Building Trust-First Care for Serious Mental Illness</a> was originally published in <a href="https://medium.com/wharton-pulse-podcast">The Pulse by Wharton Digital Health</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>